Teknik & Rekayasa editorial
Open AccessOA2024
Tackling breast cancer with gold nanoparticles: twinning synthesis and particle engineering with efficacy
This review explores the synthesis and engineering of gold nanoparticles for breast cancer theranostics, highlighting their unique properties and the challenges of clinical translation due to toxicity.
Suvadeep Mal; Subhasis Chakraborty; M. Mahapatra; K. Pakeeraiah; Suvadra Das; S. Paidesetty; Partha Royยท Nanoscale Advancesยท 2024ยท DOI 10.1039/d3na00988b
The core problem
Breast cancer remains the most prevalent cancer among women worldwide, as identified by the World Health Organization. Current treatment modalities include surgery, hormonal therapy, chemotherapy, and radiation therapy. However, site-directed nanotherapeutics with multidimensional functionality are emerging as frontrunners in breast cancer diagnosis and treatment. Gold nanoparticles (AuNPs) have become a valuable tool due to their unique colloidal, optical, quantum, magnetic, mechanical, and electrical properties. Their advantages include facile modulation of shape and size, high reproducibility and stability, biocompatibility, and ease of particle engineering to induce multifunctionality. The surface plasmon oscillation and high atomic number of gold provide distinct advantages for tailor-made diagnosis, therapy, or theranostic applications in breast cancer, such as photothermal therapy, radiotherapy, molecular labeling, imaging, and sensing. Despite promising preclinical and clinical data, clinical translation is hampered by toxicity signs in major organs like the liver, kidneys, and spleen. This has instigated global scientific brainstorming to explore feasible particle synthesis and engineering techniques to simultaneously improve efficacy and versatility and widen the safety window of gold nanoparticles. The present work marks the first study on gold nanoparticle design and maneuvering techniques, elucidating their impact on pharmacodynamics and providing a clear-cut scientific roadmap for their fast-track entry into clinical practice.
Innovation
The authors conducted a comprehensive review of the literature on gold nanoparticle synthesis, engineering, and applications in breast cancer. They analyzed various synthesis methods, including chemical reduction, seed-mediated growth, and green synthesis, and their impact on particle size, shape, and surface properties. The review also covers engineering techniques such as surface functionalization with targeting ligands (e.g., antibodies, peptides, aptamers) and loading with therapeutic agents. The pharmacodynamics of AuNPs were evaluated in terms of biodistribution, cellular uptake, and toxicity. The study synthesizes data from preclinical and clinical studies to identify key factors influencing efficacy and safety. The authors propose a roadmap for clinical translation by optimizing synthesis and engineering parameters to enhance therapeutic index and reduce toxicity. The methodology involves a systematic analysis of the literature, though specific details of the search strategy and inclusion criteria are not provided in the raw content.
Introduction
Breast cancer remains the most prevalent cancer among women worldwide, as identified by the World Health Organization. Current treatment modalities include surgery, hormonal therapy, chemotherapy, and radiation therapy. However, site-directed nanotherapeutics with multidimensional functionality are emerging as frontrunners in breast cancer diagnosis and treatment. Gold nanoparticles (AuNPs) have become a valuable tool due to their unique colloidal, optical, quantum, magnetic, mechanical, and electrical properties. Their advantages include facile modulation of shape and size, high reproducibility and stability, biocompatibility, and ease of particle engineering to induce multifunctionality. The surface plasmon oscillation and high atomic number of gold provide distinct advantages for tailor-made diagnosis, therapy, or theranostic applications in breast cancer, such as photothermal therapy, radiotherapy, molecular labeling, imaging, and sensing. Despite promising preclinical and clinical data, clinical translation is hampered by toxicity signs in major organs like the liver, kidneys, and spleen. This has instigated global scientific brainstorming to explore feasible particle synthesis and engineering techniques to simultaneously improve efficacy and versatility and widen the safety window of gold nanoparticles. The present work marks the first study on gold nanoparticle design and maneuvering techniques, elucidating their impact on pharmacodynamics and providing a clear-cut scientific roadmap for their fast-track entry into clinical practice.
Why it matters
The authors discuss the twinning of synthesis and particle engineering to optimize efficacy and safety. They emphasize that rational design of AuNPs requires careful consideration of physical and chemical properties. For instance, the aspect ratio of gold nanorods can be tuned to absorb light in the near-infrared region for deep tissue penetration. Surface functionalization with tumor-specific ligands enhances selectivity. However, the review acknowledges challenges such as scalability, reproducibility, and regulatory hurdles. The toxicity of AuNPs is a major concern; long-term accumulation in organs may lead to adverse effects. The authors propose strategies to mitigate toxicity, including biodegradable coatings and clearance-promoting designs. They also highlight the need for standardized characterization and safety assessment protocols. The pharmacodynamics of AuNPs are influenced by protein corona formation, which can alter targeting and clearance. The review concludes that a multidisciplinary approach integrating material science, biology, and clinical oncology is essential for successful translation. The roadmap includes: (1) development of reproducible synthesis methods, (2) thorough preclinical toxicity studies, (3) design of multifunctional particles with controlled release, and (4) early engagement with regulatory agencies. The authors stress that while AuNPs hold great promise, their clinical adoption requires overcoming these barriers through collaborative research.
Who should read this
Pembaca Research Digest dan praktisi rumpun ini.
Opening member contentโฆ